Login to Your Account

Other News To Note

Monday, June 13, 2011
Biota Scientific Management Pty. Ltd., of Melbourne, Australia, was awarded a five-year, $2.9 million grant from the National Institute of Allergy and Infectious Diseases to fund preclinical development of a candidate for the treatment of Clostridium difficile infection.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription